Evaluating Antifibrotic Effects of ATX Inhibitor
Corresponding Organization :
Other organizations : The University of Tokyo, Tosoh (Japan), Japan Science and Technology Agency
Protocol cited in 9 other protocols
Variable analysis
- ATX treatment (44 µM)
- HA 130 (ATX inhibitor, 1 µM) added 30 min before ATX treatment
- Protein expression of α-SMA
- Protein expression of fibronectin
- Protein expression of collagen type I
- Serum starvation for 24 hours before treatment
- Cell collection and protein extraction in RIPA buffer with protease inhibitors
- Protein quantification by BCA assay
- SDS-PAGE separation of proteins
- Transfer of proteins to PVDF membranes
- Primary antibodies: anti-α-SMA, anti-fibronectin, anti-collagen type I
- Secondary HRP-conjugated antibody
- β-tubulin as loading control
- Positive control: Cells treated with ATX (44 µM)
- Negative control: Cells treated with ATX (44 µM) and HA 130 (1 µM)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!